Last reviewed · How we verify

NCT03553706: DownSy

Indicators of Growth, Nutritional Status and Comorbide Disorders of Newborns With Down Syndrome

Completed Last updated 12 June 2018
What this trial tests

trial in Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction in 141 participants. Completed in 30 May 2018.

Timeline
20 May 2018
Primary endpoint
30 May 2018
30 May 2018

Quick facts

Lead sponsorUniversity Hospital of Split
StatusCompleted
Study typeOBSERVATIONAL
Enrollment141
Start date20 May 2018
Primary completion30 May 2018
Estimated completion30 May 2018
Sites1 location across Croatia

Conditions studied

Sponsor

University Hospital of Split

Who can join

Adults 1 Day to 1 Month, any sex, with Down Syndrome,Auxological Indexes, Auxological Parametars, Intrauterine Growth Restriction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective To access predictive values of the auxological parameters and indexes for risk of comorbid malformations in newborns with Down syndrome (DS) Study design In this cohort retrospective study, 141 newborns with proven trisomy 21 born at the Department of Gynecology and Obstetrics of the University of Split Hospital (1990 to 2015) were included. The data were obtained from the medical histories of mothers, infants and the delivery protocol. The objective was to access predictive values of the auxological parameters and indexes for risk of comorbid malformations in newborns with Down syndrome (DS) Conclusion Higher CI were found in hyportrophic (SGA) newborns with DS and indicated their intrauterine growth restriction with brain sparing and increased further risk of severe psychomotor retardation. The SGA newborns have lower parameters and indexes of nutritive status and significantly differed from eutrophic and hypertrophic newborns. These SGA newborns with DS have increased developmental risks and that requires further diagnostic attention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of Neonatal Body (Dis)Proportionality Determined by the Cephalization Index (CI) on Gross Motor Development in Children with Down Syndrome: A Prospective Cohort Study.
    Rota Čeprnja A, Pranić SM, Šunj M, Kozina T, et al · · 2022 · PMID 36670564 · DOI 10.3390/children10010013

Verify or expand the search:

Other University Hospital of Split trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03553706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing